— Know what they know.
Not Investment Advice
Also trades as: 0LTI.L (LSE) · $vol 0M

WAT NYSE

Waters Corporation
1W: +5.8% 1M: +5.8% 3M: +23.5% YTD: +22.7% 1Y: +30.3% 3Y: +84.7% 5Y: +34.0%
$468.55
+12.57 (+2.76%)
 
Weekly Expected Move ±3.8%
$419 $436 $454 $471 $488
NYSE · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Buy · Power 67 · $46.0B mcap · 98M float · 0.851% daily turnover · Short 65% of daily vol
Credit Risk of going bust: lower than 76% of companies Debt: 10.2% of company value Bonds: $314.4M held by 260 funds, 67 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $3.80 (down 99.2%), Waters Corporation would be worth roughly what it owes.
Total debt $5.25B against a stock market value of $46.00B.
Distance to default 8.84 (Merton model): prices to 2026-10-27, balance sheet 2026-07-04, debt counted $2.44B (short-term plus half of long-term), stock volatility 35.3%; Altman Z'' 3.66. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
33.5 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 1.5%  ·  5Y Avg: 25.2%
Cost Advantage
30
Intangibles
14
Switching Cost
12
Network Effect
55
Scale ★
85
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. WAT has No discernible competitive edge (33.5/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. ROIC of 1.5% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$400
Low
$462
Avg Target
$515
High
Based on 11 analysts since Aug 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 19Hold: 16Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$461.82
Analysts11
Consensus Change History
DateFieldFromTo
2026-08-15 consensus Hold Buy
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-07 Barclays — $460 $500 +40 +14.6% $436.45
2026-10-01 Guggenheim Subbu Nambi $440 $490 +50 +12.3% $436.32
2026-09-21 Goldman Sachs Evie Koslosky $425 $515 +90 +22.1% $421.63
2026-09-09 UBS Doug Schenkel $375 $490 +115 +21.6% $402.91
2026-08-27 Piper Sandler — $400 $480 +80 +15.9% $414.17
2026-08-05 Morgan Stanley — $390 $430 +40 +7.5% $400.03
2026-08-05 Deutsche Bank — $350 $400 +50 +0.4% $398.49
2026-08-05 Evercore ISI Vijay Kumar $410 $420 +10 +6.6% $394.18
2026-08-05 RBC Capital — $435 $475 +40 +20.4% $394.58
2026-08-05 Stifel Nicolaus Daniel Arias Initiated $420 — +6.0% $396.08
2026-08-05 Barclays Luke Sergott $425 $460 +35 +16.1% $396.08
2026-07-14 Goldman Sachs Evie Koslosky Initiated $425 — +13.9% $373.22
2026-07-09 Morgan Stanley Kallum Titchmarsh $350 $390 +40 +5.9% $368.13
2026-07-08 RBC Capital — Initiated $435 — +18.2% $368.13
2026-07-06 Evercore ISI — $300 $410 +110 +9.2% $375.38
2026-06-11 Piper Sandler — Initiated $400 — +10.1% $363.18
2026-06-03 HSBC — Initiated $435 — +17.0% $371.93
2026-05-07 Deutsche Bank — $315 $350 +35 -0.4% $351.33
2026-05-07 Barclays — $400 $425 +25 +21.6% $349.53
2026-05-06 UBS — $370 $375 +5 +6.3% $352.64
2026-05-06 Robert W. Baird — $363 $387 +24 +12.9% $342.75
2026-02-22 Morgan Stanley — $423 $350 -73 +5.0% $333.33
2026-02-10 UBS — Initiated $370 — +12.9% $327.59
2026-02-10 Robert W. Baird — $374 $363 -11 +11.3% $326.16
2026-02-10 Barclays — $300 $400 +100 +21.9% $328.14
2026-01-06 Guggenheim Subbu Nambi Initiated $440 — +11.4% $394.97
2025-12-15 Wells Fargo Brandon Couillard $380 $415 +35 +7.7% $385.33
2025-12-10 Wolfe Research Doug Schenkel Initiated $480 — +24.3% $386.16
2025-12-01 Morgan Stanley — Initiated $423 — +6.3% $397.79
2025-10-08 Redburn Partners Natalya Davies Initiated $390 — +22.5% $318.35
2025-08-05 Deutsche Bank — Initiated $315 — +12.0% $281.19
2025-08-04 Jefferies — $415 $385 -30 +34.8% $285.59
2025-07-11 Scotiabank Sung Ji Nam Initiated $465 — +31.8% $352.70
2025-05-07 Robert W. Baird Catherine Ramsey Schulte $407 $374 -33 +10.3% $339.02
2025-04-16 Bernstein Eve Burstein Initiated $400 — +24.6% $321.10
2025-03-26 Robert W. Baird Catherine Ramsey Schulte Initiated $407 — +10.7% $367.79
2024-10-17 CFRA Jonathan Sakraida Initiated $389 — +12.0% $347.31
2024-10-08 Jefferies Tycho Peterson $320 $415 +95 +18.6% $349.92
2024-08-27 Wells Fargo Brandon Couillard $315 $380 +65 +12.8% $336.77
2024-08-01 Barclays Luke Sergott Initiated $300 — -14.9% $352.53
2024-07-02 Evercore ISI Vijay Kumar $320 $300 -20 +6.1% $282.70
2024-06-03 Jefferies Tycho Peterson Initiated $320 — +3.6% $308.90
2024-05-07 Evercore ISI Vijay Kumar $365 $320 -45 -1.9% $326.06
2022-07-12 Evercore ISI Vijay Kumar Initiated $365 — +6.9% $341.41
2022-04-25 Wells Fargo — Initiated $315 — +6.3% $296.44

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
Oct 27, 2026
DCF
3
ROE
2
ROA
3
D/E
2
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. WAT receives an overall rating of B-. Areas of concern: ROE (2/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-08-11 B B-
2026-08-06 B- B
2026-08-04 B B-
2026-04-01 B+ B
2026-03-31 B B+
2026-03-02 B+ B
2026-02-17 B B+
2026-01-30 B+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 47 Grade B
Profitability
16
Balance Sheet
44
Earnings Quality
70
Growth
40
Value
35
Momentum
70
Safety
80
Cash Flow
43
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. WAT scores highest in Safety (80/100) and lowest in Profitability (16/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.25
Safe Zone
Piotroski F-Score
5/9
✓ ✓ ✗ ✓ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
-0.61
Possible Manipulator
Ohlson O-Score
-8.62
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB+
Score: 49.0/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 3.31x
Accruals: -2.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. WAT scores 3.25, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. WAT scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. WAT's score of -0.61 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. WAT's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. WAT receives an estimated rating of BB+ (score: 49.0/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). WAT's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
116.55x
PEG
-1.82x
P/S
9.91x
P/B
3.03x
P/FCF
93.48x
P/OCF
67.74x
EV/EBITDA
46.85x
EV/Revenue
9.04x
EV/EBIT
124.31x
EV/FCF
105.31x
Earnings Yield
0.45%
FCF Yield
1.07%
Shareholder Yield
0.04%
Graham Number
$76.74
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 116.6x earnings, WAT is priced for high growth expectations. Graham's intrinsic value formula yields $76.74 per share, 511% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.809
NI / EBT
×
Interest Burden
0.608
EBT / EBIT
×
EBIT Margin
0.073
EBIT / Rev
×
Asset Turnover
0.315
Rev / Assets
×
Equity Multiplier
1.698
Assets / Equity
=
ROE
1.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. WAT's ROE of 1.9% is driven by Asset Turnover (0.315), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$14.38
Price/Value
26.38x
Margin of Safety
-2537.64%
Premium
2537.64%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with WAT's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. WAT trades at a 2538% premium to its adjusted intrinsic value of $14.38, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 116.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$468.55
Median 1Y
$496.20
5th Pctile
$286.49
95th Pctile
$859.19
Ann. Volatility
33.2%
Analyst Target
$461.82
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Udit Batra, Ph.D.,
President & CEO
$1,150,000 $7,430,247 $13,973,044
Amol Chaubal, SVP
& CFO
$650,000 $1,732,598 $3,844,298
Jianqing Y. Bennett,
SVP, TA & Clinical Division
$633,000 $1,280,262 $2,966,345
Robert Carpio III,
SVP, Waters Division
$600,000 $1,129,966 $2,819,704

CEO Pay Ratio

149:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $13,973,044
Avg Employee Cost (SGA/emp): $93,705
Employees: 7,900

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
7,900
+4.0% YoY
Revenue / Employee
$400,669
Rev: $3,165,286,000
Profit / Employee
$81,345
NI: $642,629,000
SGA / Employee
$93,705
Avg labor cost proxy
R&D / Employee
$24,706
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 5.5% 2.3% 2.3% 2.1% 2.0% 1.6% 1.4% 1.2% 1.0% 77.6% 65.0% 54.6% 49.6% 42.8% 40.8% 37.0% 33.0% 29.3% 5.2% 1.9% 1.91%
ROA 24.0% 23.3% 22.5% 22.9% 22.5% 22.2% 21.7% 17.8% 17.3% 16.2% 15.4% 13.2% 13.8% 13.9% 14.4% 14.4% 13.8% 13.3% 3.1% 1.1% 1.13%
ROIC 52.7% 50.5% 51.9% 47.5% 46.2% 43.7% 42.8% 22.6% 22.4% 22.3% 22.4% 21.3% 21.9% 21.8% 22.7% 21.2% 20.7% 21.2% 2.7% 1.5% 1.50%
ROCE 35.0% 35.3% 36.7% 37.4% 36.8% 35.5% 34.7% 23.2% 22.8% 21.8% 21.7% 21.3% 22.1% 22.4% 23.7% 23.2% 23.3% 16.1% 2.8% 1.5% 1.51%
Gross Margin 58.9% 58.0% 58.6% 57.0% 56.7% 59.4% 58.5% 59.3% 59.1% 61.2% 58.9% 59.3% 59.3% 60.1% 58.2% 58.3% 59.0% 59.8% 47.0% 44.6% 44.62%
Operating Margin 29.1% 31.3% 28.3% 27.9% 27.1% 33.3% 25.4% 27.0% 25.2% 32.2% 21.0% 26.7% 28.5% 33.5% 22.9% 24.4% 24.0% 33.3% -3.7% -5.2% -5.23%
Net Margin 24.5% 25.9% 23.1% 23.1% 22.0% 26.4% 20.6% 20.3% 18.9% 26.4% 16.0% 20.1% 21.8% 26.5% 18.3% 19.1% 18.6% 24.2% -5.7% -8.3% -8.27%
EBITDA Margin 34.4% 35.5% 33.4% 33.3% 32.2% 37.4% 30.8% 32.7% 32.5% 38.6% 29.7% 33.9% 35.5% 39.5% 31.2% 31.6% 31.2% 34.9% 8.4% 13.1% 13.07%
FCF Margin 22.9% 20.8% 19.7% 16.7% 16.0% 14.7% 14.6% 12.9% 13.0% 15.0% 17.7% 19.5% 21.3% 20.9% 20.8% 20.3% 19.4% 17.1% 7.0% 8.6% 8.58%
OCF Margin 29.1% 26.8% 25.3% 22.1% 21.4% 20.6% 20.6% 19.1% 19.1% 20.4% 23.0% 24.5% 25.9% 25.8% 25.4% 24.5% 23.4% 20.6% 10.3% 11.8% 11.84%
ROE 3Y Avg snapshot only 24.63%
ROE 5Y Avg snapshot only 68.08%
ROA 3Y Avg snapshot only 9.36%
ROIC 3Y Avg snapshot only 12.41%
ROIC Economic snapshot only 1.47%
Cash ROA snapshot only 2.22%
Cash ROIC snapshot only 2.76%
CROIC snapshot only 2.00%
NOPAT Margin snapshot only 6.44%
Pretax Margin snapshot only 4.42%
R&D / Revenue snapshot only 6.93%
SGA / Revenue snapshot only 26.05%
SBC / Revenue snapshot only 1.58%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 31.68 33.03 26.70 29.03 23.24 28.87 26.66 23.32 24.88 30.40 33.90 28.95 34.15 34.69 32.91 31.79 26.81 35.32 55.63 224.20 116.555
P/S Ratio 8.05 8.22 6.56 7.03 5.49 6.88 6.19 5.26 5.42 6.60 7.03 6.00 7.32 7.48 7.25 6.90 5.60 7.17 6.63 8.02 9.906
P/B Ratio 74.57 62.27 50.16 51.99 42.04 40.50 30.62 20.39 17.94 16.97 16.28 12.22 13.26 12.10 11.02 9.73 7.46 8.86 1.63 2.45 3.028
P/FCF 35.16 39.53 33.26 42.08 34.25 46.86 42.41 40.66 41.64 44.16 39.80 30.75 34.29 35.71 34.92 33.94 28.88 42.05 94.66 93.48 93.481
P/OCF 27.63 30.63 25.88 31.81 25.66 33.40 30.08 27.51 28.44 32.39 30.58 24.45 28.27 29.03 28.50 28.20 23.89 34.79 64.08 67.74 67.740
EV/EBITDA 23.33 24.34 19.89 21.70 17.50 21.25 19.50 18.09 18.40 21.55 22.73 19.46 22.65 22.68 21.61 20.99 17.64 22.95 32.56 46.85 46.845
EV/Revenue 8.43 8.59 6.92 7.42 5.89 7.27 6.56 6.06 6.18 7.30 7.65 6.61 7.86 7.94 7.64 7.29 5.93 7.43 7.98 9.04 9.035
EV/EBIT 26.93 28.10 22.96 25.09 20.20 24.38 22.39 20.87 21.61 25.83 27.97 24.20 27.96 27.83 26.45 25.80 21.88 28.73 48.89 124.31 124.314
EV/FCF 36.82 41.31 35.08 44.45 36.76 49.57 44.90 46.84 47.42 48.79 43.30 33.89 36.82 37.93 36.78 35.83 30.58 43.57 114.01 105.31 105.315
Earnings Yield 3.2% 3.0% 3.7% 3.4% 4.3% 3.5% 3.8% 4.3% 4.0% 3.3% 2.9% 3.5% 2.9% 2.9% 3.0% 3.1% 3.7% 2.8% 1.8% 0.4% 0.45%
FCF Yield 2.8% 2.5% 3.0% 2.4% 2.9% 2.1% 2.4% 2.5% 2.4% 2.3% 2.5% 3.3% 2.9% 2.8% 2.9% 2.9% 3.5% 2.4% 1.1% 1.1% 1.07%
EV/OCF snapshot only 76.315
EV/Gross Profit snapshot only 17.792
Acquirers Multiple snapshot only 113.508
Shareholder Yield snapshot only 0.04%
Graham Number snapshot only $76.74
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.47 2.39 2.30 2.10 2.15 2.24 2.21 2.08 2.19 2.22 1.94 2.10 2.02 2.11 1.81 1.75 1.53 — 1.79 1.86 1.861
Quick Ratio 1.89 1.87 1.75 1.55 1.55 1.66 1.59 1.41 1.46 1.57 1.30 1.42 1.38 1.51 1.28 1.22 1.08 — 1.13 1.29 1.287
Debt/Equity 5.75 4.36 4.08 4.00 4.23 3.30 2.61 3.53 2.86 2.12 1.70 1.48 1.19 0.93 0.78 0.71 0.64 0.55 0.36 0.35 0.346
Net Debt/Equity 3.54 2.81 2.74 2.93 3.08 2.34 1.80 3.10 2.49 1.78 1.43 1.25 0.98 0.75 0.59 0.54 0.44 0.32 0.33 0.31 0.310
Debt/Assets 0.55 0.52 0.50 0.52 0.53 0.51 0.47 0.60 0.58 0.53 0.47 0.47 0.42 0.37 0.33 0.33 0.31 0.28 0.23 0.21 0.212
Debt/EBITDA 1.72 1.63 1.54 1.58 1.64 1.64 1.57 2.72 2.58 2.44 2.18 2.14 1.89 1.64 1.46 1.45 1.42 1.37 6.03 5.87 5.865
Net Debt/EBITDA 1.06 1.05 1.03 1.16 1.19 1.16 1.08 2.39 2.24 2.04 1.84 1.80 1.56 1.33 1.09 1.11 0.98 0.80 5.53 5.26 5.264
Interest Coverage 18.98 18.94 19.18 19.31 18.79 18.17 16.64 13.56 10.43 8.45 7.24 7.12 8.06 9.42 10.98 12.46 11.34 12.82 6.31 2.44 2.442
Equity Multiplier 10.55 8.42 8.11 7.75 7.97 6.50 5.51 5.90 4.97 4.02 3.59 3.15 2.81 2.49 2.34 2.18 2.09 1.98 1.60 1.63 1.629
Cash Ratio snapshot only 0.225
Debt Service Coverage snapshot only 6.479
Cash to Debt snapshot only 0.103
FCF to Debt snapshot only 0.076
Defensive Interval snapshot only 463.6 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.94 0.94 0.92 0.94 0.95 0.93 0.93 0.79 0.79 0.75 0.74 0.64 0.64 0.64 0.66 0.66 0.66 0.66 0.26 0.32 0.315
Inventory Turnover 3.15 3.50 3.35 3.20 3.01 3.08 2.83 2.62 2.48 2.46 2.26 2.19 2.20 2.42 2.31 2.35 2.33 2.48 1.69 2.38 2.384
Receivables Turnover 5.33 4.70 4.95 4.91 5.20 4.45 4.60 4.49 4.86 4.15 4.44 4.41 4.47 4.12 4.45 4.55 4.38 4.05 3.06 3.42 3.419
Payables Turnover 15.09 13.69 13.60 13.41 13.49 13.13 13.35 13.79 13.89 13.43 13.05 14.47 13.42 13.00 12.91 14.16 12.12 26.04 4.82 4.76 4.757
DSO 69 78 74 74 70 82 79 81 75 88 82 83 82 89 82 80 83 90 119 107 106.8 days
DIO 116 104 109 114 121 119 129 139 147 148 162 167 166 151 158 156 156 147 216 153 153.1 days
DPO 24 27 27 27 27 28 27 26 26 27 28 25 27 28 28 26 30 14 76 77 76.7 days
Cash Conversion Cycle 160 155 156 161 164 173 181 194 196 209 216 224 220 212 211 210 210 223 260 183 183.2 days
Fixed Asset Turnover snapshot only 2.504
Operating Cycle snapshot only 259.9 days
Cash Velocity snapshot only 8.616
Capital Intensity snapshot only 5.329
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 19.2% 17.8% 14.3% 8.6% 7.8% 6.7% 3.4% 3.2% 1.5% -0.5% -1.9% -3.9% -3.0% 0.1% 2.6% 5.9% 6.9% 7.0% 26.4% 52.5% 52.47%
Net Income 37.9% 32.8% 14.3% 6.3% 0.3% 2.2% -2.2% -3.9% -6.3% -9.3% -12.4% -11.7% -4.7% -0.7% 8.9% 11.0% 4.2% 0.8% -31.6% -74.9% -74.88%
EPS 38.8% 35.2% 17.5% 9.2% 3.3% 5.2% 0.5% -1.5% -5.0% -8.7% -12.6% -12.3% -5.1% -1.2% 8.4% 10.6% 4.0% 0.6% -50.3% -84.7% -84.74%
FCF 16.8% -6.3% -18.8% -24.6% -24.5% -24.7% -23.4% -20.1% -17.5% 1.4% 18.7% 45.0% 58.9% 40.1% 20.5% 10.4% -2.9% -12.9% -57.4% -35.7% -35.67%
EBITDA 32.4% 25.1% 10.8% 4.0% 0.5% 3.5% 0.0% 1.0% 1.2% -1.6% -1.8% -2.5% 0.3% 3.5% 7.6% 8.2% 3.6% -1.1% -12.3% -15.3% -15.28%
Op. Income 33.2% 27.3% 13.0% 7.5% 3.2% 6.3% 0.7% 0.4% -1.1% -6.4% -8.8% -10.1% -4.9% 1.1% 8.6% 10.0% 3.3% 2.0% -23.7% -56.2% -56.16%
OCF Growth snapshot only -26.23%
Asset Growth snapshot only 4.25%
Equity Growth snapshot only 6.04%
Debt Growth snapshot only 2.42%
Shares Change snapshot only 64.62%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 4.6% 4.8% 6.1% 6.4% 7.0% 7.3% 8.0% 9.5% 9.3% 7.7% 5.0% 2.5% 2.0% 2.0% 1.3% 1.6% 1.7% 2.1% 8.3% 15.8% 15.78%
Revenue 5Y 5.2% 5.1% 5.5% 5.6% 5.6% 5.2% 4.8% 4.7% 4.6% 4.1% 3.9% 3.6% 3.8% 4.2% 4.8% 6.0% 6.2% 6.0% 8.5% 11.7% 11.70%
EPS 3Y 1.5% 12.7% 12.3% 11.6% 10.3% 8.8% 10.7% 11.3% 10.9% 9.1% 1.1% -1.9% -2.3% -1.8% -1.6% -1.5% -2.1% -3.2% -22.2% -47.1% -47.10%
EPS 5Y 12.9% 11.9% 11.9% 11.8% 11.3% 1.2% 1.0% 77.7% 72.6% 6.6% 4.5% 3.7% 3.9% 3.0% 5.1% 6.0% 6.1% 5.2% -11.1% -30.8% -30.75%
Net Income 3Y 1.3% 5.3% 6.0% 6.6% 6.5% 6.1% 8.7% 9.4% 9.0% 7.2% -0.7% -3.4% -3.6% -2.7% -2.3% -2.0% -2.4% -3.2% -13.3% -37.3% -37.32%
Net Income 5Y 6.9% 5.8% 5.7% 5.5% 4.9% 1.0% 91.6% 67.9% 63.8% 1.6% 0.4% 0.6% 1.5% 1.5% 4.1% 5.1% 5.2% 4.3% -6.1% -24.1% -24.12%
EBITDA 3Y 4.2% 5.4% 7.2% 7.1% 7.3% 6.9% 8.6% 9.8% 10.4% 8.4% 2.8% 0.8% 0.7% 1.8% 1.9% 2.1% 1.7% 0.3% -2.5% -3.7% -3.66%
EBITDA 5Y 6.8% 5.8% 5.8% 5.5% 5.1% 4.8% 3.5% 3.1% 2.9% 3.6% 3.9% 3.9% 4.6% 4.5% 6.2% 6.9% 6.9% 5.5% 0.5% -1.2% -1.25%
Gross Profit 3Y 4.4% 4.5% 6.0% 6.2% 6.5% 7.3% 8.2% 10.0% 10.6% 9.0% 6.0% 3.4% 2.5% 2.6% 1.7% 2.2% 2.5% 2.6% 6.5% 10.4% 10.43%
Gross Profit 5Y 5.2% 5.0% 5.4% 5.3% 5.1% 4.8% 4.4% 4.5% 4.6% 4.3% 4.2% 4.1% 4.3% 4.7% 5.4% 6.5% 6.9% 6.5% 7.3% 8.7% 8.71%
Op. Income 3Y 4.3% 3.6% 5.7% 5.9% 5.8% 7.2% 9.1% 10.4% 10.7% 8.2% 1.3% -1.0% -1.0% 0.2% -0.1% -0.2% -1.0% -1.2% -8.9% -24.3% -24.30%
Op. Income 5Y 6.6% 5.6% 6.1% 6.1% 5.8% 5.7% 4.4% 3.6% 3.0% 2.0% 1.6% 1.4% 2.2% 3.1% 5.2% 5.9% 5.9% 5.5% -3.0% -14.1% -14.09%
FCF 3Y 8.6% 6.7% 6.6% 0.7% -1.2% -3.1% 0.3% -7.9% -10.0% -10.6% -9.6% -4.4% -0.3% 2.3% 3.1% 8.5% 8.4% 7.4% -15.2% 1.0% 0.99%
FCF 5Y 4.3% 1.6% 0.4% -3.5% -4.5% -6.4% -6.6% -6.3% -4.4% -1.5% 1.9% 3.4% 4.8% 5.3% 7.6% 4.6% 2.4% -2.7% -17.6% -9.1% -9.11%
OCF 3Y 9.0% 7.3% 6.3% 0.5% -0.1% -1.7% -0.5% -6.1% -7.2% -8.6% -7.9% -4.2% -1.9% 0.7% 1.4% 5.2% 4.9% 2.2% -13.9% -1.3% -1.29%
OCF 5Y 5.5% 3.5% 2.5% -0.7% -1.4% -2.6% -2.7% -1.7% -1.5% -0.1% 2.1% 2.3% 3.5% 3.5% 4.2% 1.5% 0.4% -3.8% -14.6% -7.3% -7.26%
Assets 3Y -8.3% -6.0% -2.2% 2.5% 6.2% 8.7% 7.4% 19.8% 18.8% 17.7% 12.0% 12.8% 13.1% 13.7% 14.7% 15.8% 16.6% 15.7% 95.0% 75.9% 75.89%
Assets 5Y -7.4% -7.9% -8.8% -9.5% -9.9% -9.3% -5.9% 1.8% 2.2% 4.4% 6.8% 9.5% 12.0% 12.2% 11.5% 12.2% 12.7% 12.4% 50.2% 51.5% 51.48%
Equity 3Y -46.0% -38.3% -27.1% -11.0% 49.4% — — — — 70.5% 75.9% 73.9% 75.8% 70.7% 73.6% 76.6% 82.2% 71.9% 1.9% 1.7% 1.70%
Book Value 3Y -41.9% -34.0% -22.8% -6.8% 54.8% — — — — 73.5% 79.0% 76.5% 78.1% 72.4% 74.8% 77.4% 82.7% 71.8% 1.6% 1.3% 1.28%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.66 0.70 0.80 0.76 0.74 0.76 0.82 0.77 0.76 0.77 0.83 0.81 0.80 0.82 0.76 0.74 0.75 0.82 0.75 0.56 0.560
Earnings Stability 0.11 0.28 0.33 0.35 0.34 0.59 0.62 0.63 0.60 0.34 0.27 0.21 0.24 0.22 0.22 0.16 0.12 0.09 0.38 0.49 0.490
Margin Stability 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.98 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.98 0.98 0.97 0.94 0.936
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.85 0.87 0.94 0.97 1.00 0.99 0.99 0.98 0.97 0.96 0.95 0.95 0.98 1.00 0.96 0.96 0.98 1.00 0.87 0.50 0.500
Earnings Smoothness 0.68 0.72 0.87 0.94 1.00 0.98 0.98 0.96 0.94 0.90 0.87 0.88 0.95 0.99 0.92 0.90 0.96 0.99 0.62 0.00 0.000
ROE Trend — — — — — -0.66 -1.12 -1.25 -1.36 -1.09 -1.03 -0.91 -0.88 -0.63 -0.48 -0.34 -0.28 -0.20 -0.38 -0.35 -0.353
Gross Margin Trend 0.01 0.01 0.01 0.00 -0.00 0.00 -0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.00 -0.00 -0.00 -0.01 -0.04 -0.09 -0.086
FCF Margin Trend 0.01 -0.02 -0.03 -0.06 -0.07 -0.09 -0.09 -0.07 -0.06 -0.03 0.01 0.05 0.07 0.06 0.05 0.04 0.02 -0.01 -0.12 -0.11 -0.113
Sustainable Growth Rate 5.5% 2.3% 2.3% 2.1% 2.0% 1.6% 1.4% 1.2% 1.0% 77.6% 65.0% 54.6% 49.6% 42.8% 40.8% 37.0% 33.0% 29.3% 5.2% 1.9% 1.91%
Internal Growth Rate 31.5% 30.5% 29.1% 29.6% 29.1% 28.5% 27.7% 21.6% 20.9% 19.4% 18.3% 15.3% 16.0% 16.1% 16.9% 16.9% 16.1% 15.4% 3.2% 1.1% 1.14%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.15 1.08 1.03 0.91 0.91 0.86 0.89 0.85 0.87 0.94 1.11 1.18 1.21 1.19 1.15 1.13 1.12 1.02 0.87 3.31 3.310
FCF/OCF 0.79 0.77 0.78 0.76 0.75 0.71 0.71 0.68 0.68 0.73 0.77 0.80 0.82 0.81 0.82 0.83 0.83 0.83 0.68 0.72 0.725
FCF/Net Income snapshot only 2.398
OCF/EBITDA snapshot only 0.614
CapEx/Revenue 6.2% 6.0% 5.6% 5.4% 5.4% 5.9% 6.0% 6.2% 6.1% 5.4% 5.3% 5.0% 4.5% 4.8% 4.7% 4.1% 4.1% 3.6% 3.3% 3.3% 3.26%
CapEx/Depreciation snapshot only 0.271
Accruals Ratio -0.04 -0.02 -0.01 0.02 0.02 0.03 0.02 0.03 0.02 0.01 -0.02 -0.02 -0.03 -0.03 -0.02 -0.02 -0.02 -0.00 0.00 -0.03 -0.026
Sloan Accruals snapshot only 0.050
Cash Flow Adequacy snapshot only 3.632
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 70.9% 93.7% 91.7% 89.6% 90.9% 88.5% 76.3% 55.4% 33.6% 10.9% 2.3% 2.3% 2.1% 2.1% 2.2% 2.2% 2.2% 2.3% 2.8% 8.6% 8.64%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 2.2% 2.8% 3.4% 3.1% 3.9% 3.1% 2.9% 2.4% 1.3% 0.4% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.04%
Net Buyback Yield 2.2% 2.8% 3.4% 3.1% 3.9% 3.1% 2.9% 2.4% 1.3% 0.4% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% -0.0% -0.0% -0.02%
Total Shareholder Return 2.2% 2.8% 3.4% 3.1% 3.9% 3.1% 2.9% 2.4% 1.3% 0.4% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% -0.0% -0.0% -0.02%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.86 0.86 0.86 0.86 0.86 0.84 0.84 0.84 0.84 0.87 0.88 0.88 0.87 0.84 0.84 0.84 0.85 0.85 0.86 0.81 0.809
Interest Burden (EBT/EBIT) 0.95 0.95 0.95 0.95 0.95 0.94 0.94 0.93 0.90 0.88 0.86 0.86 0.88 0.89 0.91 0.92 0.91 0.92 0.85 0.61 0.608
EBIT Margin 0.31 0.31 0.30 0.30 0.29 0.30 0.29 0.29 0.29 0.28 0.27 0.27 0.28 0.29 0.29 0.28 0.27 0.26 0.16 0.07 0.073
Asset Turnover 0.94 0.94 0.92 0.94 0.95 0.93 0.93 0.79 0.79 0.75 0.74 0.64 0.64 0.64 0.66 0.66 0.66 0.66 0.26 0.32 0.315
Equity Multiplier 22.85 9.90 10.32 9.30 9.09 7.31 6.51 6.52 5.86 4.78 4.21 4.12 3.59 3.08 2.83 2.57 2.38 2.20 1.69 1.70 1.698
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $11.23 $11.28 $11.56 $11.60 $11.60 $11.87 $11.61 $11.43 $11.02 $10.83 $10.15 $10.02 $10.46 $10.69 $11.00 $11.09 $10.88 $10.75 $5.47 $1.69 $1.69
Book Value/Share $4.77 $5.98 $6.15 $6.48 $6.41 $8.46 $10.11 $13.07 $15.28 $19.40 $21.14 $23.75 $26.94 $30.66 $32.86 $36.20 $39.09 $42.86 $186.17 $154.73 $154.73
Tangible Book/Share $-6.26 $-5.09 $-4.88 $-4.31 $-4.14 $-2.57 $-1.09 $-20.20 $-17.45 $-13.22 $-10.98 $-8.11 $-4.96 $-0.59 $1.70 $4.07 $7.07 $11.09 $-34.10 $-27.97 $-27.97
Revenue/Share $44.21 $45.36 $47.05 $47.94 $49.10 $49.83 $50.00 $50.71 $50.55 $49.85 $48.94 $48.38 $48.82 $49.60 $49.96 $51.06 $52.09 $52.96 $45.90 $47.29 $47.29
FCF/Share $10.12 $9.43 $9.28 $8.01 $7.87 $7.31 $7.30 $6.56 $6.58 $7.46 $8.65 $9.44 $10.42 $10.39 $10.37 $10.38 $10.10 $9.03 $3.21 $4.06 $4.06
OCF/Share $12.88 $12.17 $11.92 $10.59 $10.50 $10.26 $10.29 $9.69 $9.64 $10.16 $11.26 $11.86 $12.64 $12.78 $12.71 $12.50 $12.21 $10.92 $4.75 $5.60 $5.60
Cash/Share $10.59 $9.27 $8.25 $6.94 $7.40 $8.07 $8.21 $5.60 $5.69 $6.68 $5.69 $5.51 $5.57 $5.45 $6.41 $6.16 $7.70 $9.84 $5.62 $5.49 $5.49
EBITDA/Share $15.97 $16.00 $16.36 $16.40 $16.53 $17.05 $16.82 $16.98 $16.97 $16.88 $16.48 $16.43 $16.94 $17.38 $17.65 $17.72 $17.51 $17.15 $11.25 $9.12 $9.12
Debt/Share $27.45 $26.07 $25.12 $25.95 $27.14 $27.89 $26.42 $46.14 $43.74 $41.18 $35.98 $35.13 $32.01 $28.54 $25.73 $25.79 $24.93 $23.55 $67.81 $53.50 $53.50
Net Debt/Share $16.86 $16.80 $16.87 $19.01 $19.74 $19.82 $18.21 $40.54 $38.05 $34.50 $30.29 $29.63 $26.44 $23.09 $19.32 $19.63 $17.23 $13.71 $62.19 $48.01 $48.01
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.250
Altman Z-Prime snapshot only 6.078
Piotroski F-Score 9 7 9 6 6 6 4 4 5 4 4 5 5 6 6 6 6 5 3 5 5
Beneish M-Score -2.60 -2.52 -2.42 -2.21 -2.24 -2.19 -2.27 -1.94 -2.00 -2.08 -2.21 -2.71 -2.54 -2.54 -2.45 -2.39 -2.47 -2.34 -0.77 -0.61 -0.614
Ohlson O-Score snapshot only -8.620
Net-Net WC snapshot only $-51.84
EVA snapshot only $-1691831205.08
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB+
Credit Score 87.55 87.55 88.21 88.51 87.56 87.56 87.13 80.59 82.03 81.56 79.92 81.82 83.12 84.76 84.98 85.50 85.33 85.42 59.60 48.98 48.977
Credit Grade snapshot only 11
Credit Trend snapshot only -36.523
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 13
Sector Credit Rank snapshot only 37

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms